FDA issued a Warning Letter to BioReliance Corporation on 1/5/2009 as a result of this inspection.
483 BioReliance Sep 2008

483 BioReliance Sep 2008

Barbara Breithaupt FDA$119.00 - Available Now

FDA investigators audited the BioReliance - Rockville, MD, United States facility and issued inspectional observations (via FDA 483) on 29 Sep 2008.

Product details

  • Category: Biologics
  • Inspection end: 29 Sep 2008
  • Location: Rockville, United States
  • FEI: 1122041
Add To Cart